(Q41851242)

reason for preferred rank

13 October 2017

title

SK&F 96067 is a reversible, lumenally acting inhibitor of the gastric (H+ + K+)-ATPase (English)

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90690-7

21 October 2022

SK&F 96067 is a reversible, lumenally acting inhibitor of the gastric (H+ + K+)-ATPase (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1648919

21 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90690-7

21 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90690-7

21 October 2022

author name string

D. J. Keeling

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1648919

21 October 2022

R. C. Malcolm

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1648919

21 October 2022

S. M. Laing

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1648919

21 October 2022

R. J. Ife

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1648919

21 October 2022

C. A. Leach

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1648919

21 October 2022

language of work or name

English

0 references

publication date

1 June 1991

1 reference

13 October 2017

21 June 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1648919

full work available at URL

21 October 2022

https://api.elsevier.com/content/article/PII:0006295291906907?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90690-7

https://api.elsevier.com/content/article/PII:0006295291906907?httpAccept=text/plain

21 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90690-7

21 October 2022

published in

Biochemical Pharmacology

1 reference

13 October 2017

volume

42

1 reference

13 October 2017

issue

1

1 reference

13 October 2017

page(s)

123-130

1 reference

Effect of omeprazole--a gastric proton pump inhibitor--on pentagastrin stimulated acid secretion in man

13 October 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90690-7

Specific labelling of gastric H+,K+-ATPase by omeprazole

21 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90690-7

The specificity of omeprazole as an (H+ + K+)-ATPase inhibitor depends upon the means of its activation

21 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90690-7

By 1023/SK&F 96022: biochemistry of a novel (H+ + K+)-ATPase inhibitor

21 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90690-7

Irreversible inactivation of rat gastric (H+-K+)-ATPase in vivo by omeprazole

21 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90690-7

Omeprazole in duodenal ulceration: acid inhibition, symptom relief, endoscopic healing, and recurrence. Cooperative study

21 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90690-7

Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression

21 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90690-7

Potassium-stimulated ATPase activity and hydrogen transport in gastric microsomal vesicles

21 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90690-7

Characterization of gastric mucosal membranes. IX. Fractionation and purification of K+-ATPase-containing vesicles by zonal centrifugation and free-flow electrophoresis technique

21 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90690-7

Protein measurement with the Folin phenol reagent

21 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90690-7

On the reversibility of binding of cardiotonic steroids to a partially purified (Na+K)-activated adenosinetriphosphatase from beef brain

21 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90690-7

The Determination of Enzyme Dissociation Constants

21 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90690-7

6 Statistical analysis of enzyme kinetic data

21 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90690-7

The Yonetani-Theorell graphical method for examining overlapping subsites of enzyme active centers.

21 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90690-7

Studies on the mechanism of action of the gastric microsomal (H+ + K+)-ATPase inhibitors SCH 32651 and SCH 28080.

21 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90690-7

SCH 28080 is a lumenally acting, K+-site inhibitor of the gastric (H+ + K+)-ATPase

21 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90690-7

Reversible inhibitors of the gastric (H+/K+)-ATPase. 1. 1-Aryl-4-methylpyrrolo[3,2-c]quinolines as conformationally restrained analogues of 4-(arylamino)quinolines

21 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90690-7

21 October 2022

Identifiers

1 reference

13 October 2017

1 reference